Department of Anaesthesiology, Geneva University Hospitals, Geneva, Switzerland; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Centre for Perioperative Medicine, University College London, UK.
Br J Anaesth. 2019 Aug;123(2):228-237. doi: 10.1016/j.bja.2019.04.041. Epub 2019 May 23.
Clinical indicators are powerful tools to quantify the safety and quality of patient care. Their validity is often unclear and definitions extremely heterogeneous. As part of the International Standardised Endpoints in Perioperative Medicine (StEP) initiative, this study aimed to derive a set of standardised and valid clinical outcome indicators for use in perioperative clinical trials.
We identified clinical indicators via a systematic review of the anaesthesia and perioperative medicine literature (PubMed/OVID, EMBASE, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 54 clinician-researchers worldwide. Indicators were first shortlisted and the most suitable definitions for evaluation of quality and safety interventions determined. Indicators were then assessed for validity, reliability, feasibility, and clarity.
We identified 167 clinical outcome indicators. Participation in the three Delphi rounds was 100% (n=13), 68% (n=54), and 85% (n= 6), respectively. A final list of eight outcome indicators was generated: surgical site infection at 30 days, stroke within 30 days of surgery, death within 30 days of coronary artery bypass grafting, death within 30 days of surgery, admission to the intensive care unit within 14 days of surgery, readmission to hospital within 30 days of surgery, and length of hospital stay (with or without in-hospital mortality). They were rated by the majority of experts as valid, reliable, easy to use, and clearly defined.
These clinical indicators can be confidently used as endpoints in clinical trials measuring quality, safety, and improvement in perioperative care.
PROSPERO 2016 CRD42016042102 (http://www.crd.york.ac.uk/PROSPERO/display_record.php? ID=CRD42016042102).
临床指标是量化患者护理安全性和质量的有力工具。其有效性往往不明确,定义也极其多样。作为围手术期医学国际标准化终点(StEP)倡议的一部分,本研究旨在为围手术期临床试验制定一套标准化和有效的临床结局指标。
我们通过对麻醉和围手术期医学文献(PubMed/OVID、EMBASE 和 Cochrane Library)进行系统回顾来确定临床指标。我们进行了三阶段德尔菲共识获取过程,涉及全球 54 位临床医生-研究人员。首先对指标进行了初选,并确定了评估质量和安全干预措施的最合适定义。然后评估了指标的有效性、可靠性、可行性和清晰度。
我们确定了 167 个临床结局指标。三轮德尔菲调查的参与率分别为 100%(n=13)、68%(n=54)和 85%(n=6)。最终生成了一份 8 项结局指标清单:术后 30 天的手术部位感染、术后 30 天内的中风、冠状动脉旁路移植术后 30 天内的死亡、手术后 30 天内的死亡、手术后 14 天内入住重症监护病房、手术后 30 天内再次住院、以及住院时间(含或不含院内死亡)。大多数专家认为这些指标具有有效性、可靠性、易用性和明确的定义。
这些临床指标可作为临床试验的终点,用于衡量围手术期护理的质量、安全性和改进。
PROSPERO 2016 CRD42016042102(http://www.crd.york.ac.uk/PROSPERO/display_record.php?ID=CRD42016042102)。